MedTech News
.................... by Andrew Celentano
A redesigned endoscope offers a new way to look for early signs of ovarian cancer
Ovarian cancer remains the deadliest gynecologic cancer, largely because it is rarely found early. Symptoms are often vague, and existing screening approaches—such as blood tests and transvaginal ultrasound—can miss the disease at stages when treatment is most effective. In recent years, research has reshaped understanding of how many aggressive ovarian cancers begin, pointing not to the ovary itself, but to the fallopian tubes. That shift has created a need for tools that can safely examine these narrow structures for early changes linked to cancer.
Transcranial magnetic stimulation can target a deep brain region without surgery or medication
Neuroscientists at University of Iowa Health Care have demonstrated for the first time that noninvasive brain stimulation can alter the activity of a critical deep brain region involved in emotion and memory. Moreover, the study shows that personalizing the stimulation site using a patient’s unique brain connectivity pathway can increase the neuromodulation effect.
Zeto Announces FDA 510(k) Clearance of Zeto New Wave™, Advancing Efficiency in Outpatient EEG
RALEIGH, N.C., April 2, 2026 /PRNewswire/ — Zeto, Inc., a medical technology company dedicated to making brain health insights through EEG a foundational vital sign in healthcare, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Zeto New Wave™, its newest EEG system for outpatient clinics and homes.
MediBeacon secures CE Mark certification for TGFR monitor and sensor
Lumitrace is currently approved in China and the US, with submission to EU regulatory authorities pending.
Restore Robotics wins FDA nod to remanufacture new da Vinci instruments
Restore Robotics announced new FDA 510(k) clearances for the remanufacturing of two Intuitive da Vinci Xi robotic surgical instruments.
Vdyne wins FDA IDE to study tricuspid valve replacement
Vdyne announced today that it received FDA investigational device exemption (IDE) for a pivotal trial evaluating its heart valve system.
Simple blood test could spot dementia years earlier, research shows
A blood test could help identify people at higher risk of cognitive decline years before a traditional diagnosis is possible—according to University of East Anglia research published in the journal Gut Microbes.
FDA grants speedy approval to Eli Lilly’s weight-loss pill for obesity
Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions.